<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04731584</url>
  </required_header>
  <id_info>
    <org_study_id>69HCL20_1080</org_study_id>
    <nct_id>NCT04731584</nct_id>
  </id_info>
  <brief_title>Systemic Inflammation During Recanalization of Cerebral Arterial Occlusion</brief_title>
  <acronym>CONVASC-I</acronym>
  <official_title>Systemic Inflammation During Recanalization of Cerebral Arterial Occlusion</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospices Civils de Lyon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospices Civils de Lyon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Strokes management, secondary to proximal arterial occlusion, by endovascular thrombectomy&#xD;
      (TM) is now well established. The immuno-inflammatory events of reperfusion after TM are&#xD;
      discussed. Systemic inflammation is a major factor suggested to explain the limited recovery&#xD;
      of the ischemic parenchyma. Understanding these phenomena is necessary before developing an&#xD;
      immunomodulatory strategy.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">March 2021</start_date>
  <completion_date type="Anticipated">October 2021</completion_date>
  <primary_completion_date type="Anticipated">October 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Inflammation parameters description</measure>
    <time_frame>1 day</time_frame>
    <description>Inflammatory parameters such as CRP, IL-6, IL-10, HLA-DR, TNF-alpha, polymorphonuclear chemotaxis, CD-4, T-lymphocytes will be measure in blood sample</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Stroke</condition>
  <condition>Systemic Infection</condition>
  <arm_group>
    <arm_group_label>AVC</arm_group_label>
    <description>Patients hospitalized for TM after a proximal ischemic stroke of the middle cerebral artery and whose reperfusion is satisfactory (TICI 2b, 2c and 3). Additional blood sample will be taken during usual treatment the day of the stroke.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <description>Population of control patients, consisting of patients admitted on an outpatient basis for a diagnostic cerebral arteriography.</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Blood sample</intervention_name>
    <description>Patients from 2 groups will undergo blood sample (during a blood sample for there care) and inflammation parameters will be measure the day of the stroke</description>
    <arm_group_label>AVC</arm_group_label>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients hospitalized for TM after a proximal ischemic stroke of the middle cerebral artery&#xD;
        and whose reperfusion is satisfactory (TICI 2b, 2c and 3).&#xD;
&#xD;
        Population of control patients, consisting of patients admitted on an outpatient basis for&#xD;
        diagnostic cerebral arteriography.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        GROUP &quot;AVC&quot; :&#xD;
&#xD;
        Inclusion Criteria:&#xD;
&#xD;
          -  Adults patient (s)&#xD;
&#xD;
          -  Ischemic stroke by occlusion of a middle cerebral artery (proximal portion M1)&#xD;
&#xD;
          -  Initial diagnostic MRI infusion&#xD;
&#xD;
          -  TM with complete reperfusion (TICI 2b, 2c or 3)&#xD;
&#xD;
          -  TM performed under local anesthesia +/- anxiolysis, or sedation including propofol&#xD;
&#xD;
          -  mRS prior to stroke &lt;2&#xD;
&#xD;
          -  Barthel index &lt;90&#xD;
&#xD;
          -  Included in the HIBISCUS cohort&#xD;
&#xD;
          -  Patient who was informed and did not object to participating in the study OR included&#xD;
             through the emergency procedure then collection of his non-objection or that of his&#xD;
             trusted person as soon as possible&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  NIHSS awareness score&gt; or = 2&#xD;
&#xD;
          -  Haemorrhagic complication before thrombectomy&#xD;
&#xD;
          -  Pregnant woman&#xD;
&#xD;
          -  Multiple vascular occlusions&#xD;
&#xD;
          -  Occlusions of posterior or anterior cerebral territories other than M1&#xD;
&#xD;
          -  Protected major&#xD;
&#xD;
          -  TM performed under general anesthesia&#xD;
&#xD;
          -  Other vital failure than neurological failure&#xD;
&#xD;
        GROUP &quot;CONTROL&quot; :&#xD;
&#xD;
        Inclusion Criteria:&#xD;
&#xD;
          -  Adults patient (s)&#xD;
&#xD;
          -  mRS &lt;2&#xD;
&#xD;
          -  Barthel index &lt;90&#xD;
&#xD;
          -  Requiring diagnostic arteriography for routine check-up of a cerebrovascular&#xD;
             malformation&#xD;
&#xD;
          -  Patient who was informed and did not object to participating in the study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  NIHSS awareness score&gt; or = 2&#xD;
&#xD;
          -  Pregnant woman&#xD;
&#xD;
          -  Protected major&#xD;
&#xD;
          -  Exam performed under general anesthesia&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Baptiste BOUCHIER, Dr</last_name>
    <phone>04 72 35 75 76</phone>
    <phone_ext>+33</phone_ext>
    <email>baptiste.bouchier@chu-lyon.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Julien BERTHILLER</last_name>
    <phone>04 27 85 63 01</phone>
    <phone_ext>+33</phone_ext>
    <email>julien.berthiller@chu-lyon.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Service d'Anesthésie Réanimation Hôpital - Neurologique/Groupement Est</name>
      <address>
        <city>Bron</city>
        <zip>69500</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Baptiste BOUCHIER, Dr</last_name>
      <phone>04 72 35 75 76</phone>
      <phone_ext>+33</phone_ext>
      <email>baptiste.bouchier@chu-lyon.fr</email>
    </contact>
    <investigator>
      <last_name>Florian CONTARD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Service de Neurologie vasculaire - Hôpital Neurologique/Groupement Est</name>
      <address>
        <city>Bron</city>
        <zip>69500</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Laura MECHTOUFF, Dr</last_name>
      <phone>04 72 35 78 07</phone>
      <phone_ext>+33</phone_ext>
      <email>laura.mechtouff@chu-lyon.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Service de Neuroradiologie interventionnelle - Hôpital Neurologique/Groupement Est</name>
      <address>
        <city>Bron</city>
        <zip>69500</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Omer EKER, Pr</last_name>
      <phone>04 72 11 93 73</phone>
      <phone_ext>+33</phone_ext>
      <email>omer.eker@chu-lyon.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Service d'Anesthésie Réanimation - Hôpital Edouard Herriot/Groupement Centre</name>
      <address>
        <city>Lyon</city>
        <zip>69437</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Anne-Claire LUKASZEWICZ, Pr</last_name>
      <phone>04 72 11 13 27</phone>
      <phone_ext>+33</phone_ext>
      <email>anne-claire.lukaszewicz@chu-lyon.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>January 26, 2021</study_first_submitted>
  <study_first_submitted_qc>January 26, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 1, 2021</study_first_posted>
  <last_update_submitted>January 26, 2021</last_update_submitted>
  <last_update_submitted_qc>January 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sepsis</mesh_term>
    <mesh_term>Inflammation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

